
Emilia Yap
Articles
-
Oct 27, 2024 |
ajp.com.au | Jay Cutler |Bart Pharm |Emma Anastasi |Emilia Yap
Positivity is in the air for the community pharmacy sector following the signing of the 8CPA, with bankers happy to back owners, according to a valuations expert Market sentiment is on the rise after taking a dip in 2023 due to uncertainty caused by the federal government’s decision to implement 60-day dispensing, Christian Sirianni fromThis content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.
-
Oct 25, 2024 |
ajp.com.au | Megan Haggan |Emma Anastasi |Emilia Yap |David PerdueU. S. senator
Business news, scam warnings and a look at Ahpra notifications... it's been a busy and varied week in pharmacy This week we heard from Queensland's Office of the Health Ombudsman on the data around reports to Ahpra about pharmacists; while Victorian Labor MP Matt Fregon said many pharmacies were providing methadone to their own financialThis content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.
-
Oct 25, 2024 |
ajp.com.au | Emma Anastasi |Emilia Yap |David PerdueU. S. senator |Sheshtyn Paola
In the first of a series of podcasts co-produced by AJP and PDL, we take a look at risk awareness and management when compounding In this podcast, Kylie Neville, PDL professional officer, is joined by two highly experienced industry leaders in pharmaceutical compounding: Patricia Ullmann and Marina Holt. They delve into topics relating to riskThis content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.
-
Oct 25, 2024 |
ajp.com.au | Nicholas O’Donoghue |Emilia Yap |David PerdueU. S. senator |Sheshtyn Paola
Guild hits out at Echo Therapeutics’ decision to restrict access to a PBS-listed medication to an exclusive home delivery service Echo Therapeutics announced it was partnering with online pharmacy JustMeds to exclusively distribute its Pegasys (peginterferon alfa-2a) injections to patients, in September. The company said the shift to the home delivery service was prompted following reportsThis content is restricted to registered users only.
-
Oct 24, 2024 |
ajp.com.au | Nicholas O’Donoghue |David PerdueU. S. senator |Sheshtyn Paola |Emilia Yap
Co-founders of on-line weight management company, Eucalyptus debut on AFR Young Rich List Demand for weight-loss injectables, semaglutide and tirzepatide, has seen Eucalyptus co-founders, Tim Doyle, Charles Gearside and Benjamin Kleist, join the Australian Financial Review’s (AFR’s) Young Rich List. The trio, whose Juniper and Pilot digital clinics have seen the company become Australia’s largestThis content is restricted to registered users only.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →